ACE and hydrops fetalis: In a subgroup analysis of the HF medication group, for all-cause mortality andnon-CVD-related mortality, there was no difference in outcome with increasingexercise in HF medication group I—none or ACE inhibitor/ARB, but all-causemortality and non-CVD-related mortality were decrease with increasing exercise inHF medication group II—beta blocker or diuretics, III—spironolactone(Supplementary Table 4).